admin

European approval for 'Dovato', ViiV's dual regimen for HIV

The European Commission has approved the marketing authorization for the dolutegravir/lamivudine combination for the treatment of HIV-1 infection in adults and adolescents aged 12 years and over. Editorial Staff, July 8, 2019. ViiV Healthcare announces that the European Commission has granted marketing authorization to Dovato (dolutegravir/lamivudine) for the treatment of HIV-1 infection […]

European approval for 'Dovato', the double ViiV regimen for HIV Read More »

Don't believe these myths associated with HIV.

From: https://www.thehealthsite.com/photo-gallery/diseases-conditions-dont-believe-these-myths-associated-with-hiv-675455/taking-shower–675462 Published on: July 7, 2019 1:10 pm Tags: HIV stigma HIV positive HIV virus HIV-AIDS 1 / 6 In 2017, 940,000 people died from HIV-related illnesses worldwide. Sounds awful, right? Well, this data is concerning enough to give some serious thought to this health condition. HIV is a virus that alters

Don't believe these myths about HIV. Read More »

Clinical, microbiological, and immunological determinants of mortality in hospitalized patients with HIV-associated tuberculosis: a prospective cohort study Charlotte Schutz, David Barr, Bruno B. Andrade, Muki Shey, Amy Ward, Saskia Janssen, Rosie Burton, Katalin A. Wilkinson, Bianca Sossen, Kiyoshi F. Fukutani, Mark Nicol, Gary Maartens, Robert J. Wilkinson, Graeme Meintjes i

Background Abstract: In high-burden settings, case fatality rates are reported to be between 11% and 32% in hospitalized patients with HIV-associated tuberculosis, but the underlying causes of mortality remain poorly characterized. Understanding the causes of mortality could inform the development of new strategies.

Clinical, microbiological, and immunological determinants of mortality in hospitalized patients with HIV-associated tuberculosis: a prospective cohort study Charlotte Schutz, David Barr, Bruno B. Andrade, Muki Shey, Amy Ward, Saskia Janssen, Rosie Burton, Katalin A. Wilkinson, Bianca Sossen, Kiyoshi F. Fukutani, Mark Nicol, Gary Maartens, Robert J. Wilkinson, Graeme Meintjes i Read More »

Case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a 10-year retrospective follow-up. Diogo Gama Caetano, Fernanda Heloise Côrtes

HIV controllers (HICs) are a rare group of HIV-1-infected individuals who can naturally control viral replication. Several studies have identified the occurrence of dual HIV infections in seropositive individuals, leading to disease progression. In HICs, however, the following have been described:

Case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a 10-year retrospective follow-up. Diogo Gama Caetano, Fernanda Heloise Côrtes. Read More »

“Chemsex is associated with poorer adherence to HIV treatment”

Chemsex, also known as sex doping or the sexualized use of drugs, is a practice referring to the intentional use of psychoactive substances to enhance sexual relations, typically among gay men. The phenomenon is closely linked to the transmission of sexually transmitted infections (STIs) and, according to Pablo Ryan, attending physician in Internal Medicine at the Infanta Leonor University Hospital (Madrid), is associated with poorer adherence to contraception.

“Chemsex is associated with poorer adherence to HIV treatment” Read More »

Mortality in hospitalized patients diagnosed with Human Immunodeficiency Virus Infection

Pérez C, Guillén A, Caraballo S, Silva E, Gonzalez J, Guzman M, Comegna M. Materials and methods: Observational, retrospective and descriptive study that included patients diagnosed with HIV who died at the Vargas Hospital of Caracas (HVC) during the year 2018. The data were processed in the IBM SPSS Statistics® version 20 program and

Mortality in hospitalized patients diagnosed with Human Immunodeficiency Virus Infection Read More »